WEKO3
アイテム
Carbon ion radiotherapy for bone and soft tissue sarcomas
https://repo.qst.go.jp/records/54393
https://repo.qst.go.jp/records/54393fd3bd7e3-2b93-48b0-9e41-653fce17916d
| Item type | 会議発表論文 / Conference Paper(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2013-11-14 | |||||
| タイトル | ||||||
| タイトル | Carbon ion radiotherapy for bone and soft tissue sarcomas | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_5794 | |||||
| 資源タイプ | conference paper | |||||
| アクセス権 | ||||||
| アクセス権 | metadata only access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
| 著者 |
Kamada, Tadashi
× Kamada, Tadashi× Imai, Reiko× Serizawa, Itsuko× 鎌田 正× 今井 礼子× 芹澤 慈子 |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Carbon ion radiotherapy for bone and soft tissue sarcomas. T. Kamada, R. Imai, H. Tsujii, H. Tsuji, I. Serizawa; National Institute of Radiological Sciences, Chiba, Japan Background: Carbon ion radiotherapy showed promising clinical outcomes in 57 patients with bone and STS during the phase I study (Kamada, JCO 22 4466-4471, 2002). This phase II study was planned thereafter. Methods: From April 2000 to February 2007, 301 lesions of 282 patients with bone and STS not suited for surgical resection were enrolled in this phase II study. A total dose of 64.0 GyE in 16 fractions over 4 weeks was indicated for 15 lesions, that of 70.4 GyE for 276 and remaining 10 receiving 73.6 GyE. Mean age was 52 yrs, (range 12-85); site of origin was the pelvis in 74%, spine or para-spinous softtissue in 20%, extremities in 5%; bone primarywas in 78% and softtissue in 22%; pathologic subtype in bone sarcoma was chordoma in 42%, chondrosarcoma in 21%, osteosarcoma in 21%; pathologic subtype in STS was MFH in 23%, MPNST in 21%, synovial sarcoma in 13%. Results: The 3- and 5-year overall actuarial survival rates were 68% (95% Cl, 61%-75%) and 52% (95% Cl, 43%-61%), respectively, and the actuarial overall local control rates were 85% (95% Cl, 80%- 90%), and 81% (95% Cl, 74%-88%) at 3 years and 5 years of follow-up, respectively. Overall toxicity was acceptable, with 2% skin/soft tissue late G3/4 toxicity. Conclusions: Carbon ion radiotherapy shows a substantial local control in the patients with bone and soft tissue sarcomas not suited for surgical resection with acceptable morbidity. |
|||||
| 書誌情報 |
International Journal of Clinical Oncology 巻 26, 号 15S, p. 562S-562S, 発行日 2008-05 |
|||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 1341-9625 | |||||
